# AGILENT TECHNOLOGIES, INC. (A) FY2026 YTD Q2 P&L / Income Statement - Company: AGILENT TECHNOLOGIES, INC. (A) - Period: 2025-11-01 to 2026-04-30 - Filing: Q2 FY2026 10-Q, filed 2026-06-01, accession number 0001090872-26-000055 - Page: https://plicit.ai/financials/a/fy2026-ytd-q2-income-statement - Chart image: https://plicit.ai/charts/a-fy2026-ytd-q2-income-statement-sankey.png ## Chart details: Revenue by Product and Service Income statement for 2025-11-01 through 2026-04-30. View: Product and service (Revenue by Type). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net revenue**: 3,633,000,000 US dollars - **Cost of revenue**: 1,697,000,000 US dollars - **Gross profit (calculated)**: 1,936,000,000 US dollars - **Operating expenses (calculated)**: 1,184,000,000 US dollars - **Income from operations**: 752,000,000 US dollars - **Other income (expense), net (calculated)**: 20,000,000 US dollars - **Income before taxes**: 772,000,000 US dollars - **Provision for income taxes**: 128,000,000 US dollars - **Net income**: 644,000,000 US dollars - **Instrumentation**: 1,276,000,000 US dollars - **Non-Instrumentation and Other**: 2,357,000,000 US dollars - **Research and development**: 243,000,000 US dollars - **Selling, general and administrative**: 941,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Business Segment - Page: https://plicit.ai/financials/a/fy2026-ytd-q2-income-statement/revenue-by-business-segment - Chart image: https://plicit.ai/charts/a-fy2026-ytd-q2-revenue-by-business-segment-sankey.png Income statement for 2025-11-01 through 2026-04-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net revenue**: 3,633,000,000 US dollars - **Cost of revenue**: 1,697,000,000 US dollars - **Gross profit (calculated)**: 1,936,000,000 US dollars - **Operating expenses (calculated)**: 1,184,000,000 US dollars - **Income from operations**: 752,000,000 US dollars - **Other income (expense), net (calculated)**: 20,000,000 US dollars - **Income before taxes**: 772,000,000 US dollars - **Provision for income taxes**: 128,000,000 US dollars - **Net income**: 644,000,000 US dollars - **Life Sciences and Diagnostics Markets**: 1,411,000,000 US dollars - **Agilent CrossLab**: 1,517,000,000 US dollars - **Applied Markets**: 705,000,000 US dollars - **Research and development**: 243,000,000 US dollars - **Selling, general and administrative**: 941,000,000 US dollars - **Life Sciences and Diagnostics Markets costs (calculated)**: 1,141,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Agilent CrossLab costs (calculated)**: 1,035,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Applied Markets costs (calculated)**: 532,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Reconciling items (calculated)**: 173,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Business Segment by Geography - Page: https://plicit.ai/financials/a/fy2026-ytd-q2-income-statement/revenue-by-business-segment-by-geography - Chart image: https://plicit.ai/charts/a-fy2026-ytd-q2-revenue-by-business-segment-by-geography-sankey.png Income statement for 2025-11-01 through 2026-04-30. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net revenue**: 3,633,000,000 US dollars - **Cost of revenue**: 1,697,000,000 US dollars - **Gross profit (calculated)**: 1,936,000,000 US dollars - **Operating expenses (calculated)**: 1,184,000,000 US dollars - **Income from operations**: 752,000,000 US dollars - **Other income (expense), net (calculated)**: 20,000,000 US dollars - **Income before taxes**: 772,000,000 US dollars - **Provision for income taxes**: 128,000,000 US dollars - **Net income**: 644,000,000 US dollars - **Agilent CrossLab - Americas**: 562,000,000 US dollars - **Agilent CrossLab - Asia Pacific**: 518,000,000 US dollars - **Agilent CrossLab - Europe**: 437,000,000 US dollars - **Applied Markets - Americas**: 210,000,000 US dollars - **Applied Markets - Asia Pacific**: 313,000,000 US dollars - **Applied Markets - Europe**: 182,000,000 US dollars - **Life Sciences and Diagnostics Markets - Americas**: 670,000,000 US dollars - **Life Sciences and Diagnostics Markets - Asia Pacific**: 324,000,000 US dollars - **Life Sciences and Diagnostics Markets - Europe**: 417,000,000 US dollars - **Research and development**: 243,000,000 US dollars - **Selling, general and administrative**: 941,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Product and Service (2) - Page: https://plicit.ai/financials/a/fy2026-ytd-q2-income-statement/revenue-by-product-and-service-2 - Chart image: https://plicit.ai/charts/a-fy2026-ytd-q2-revenue-by-product-and-service-2-sankey.png Income statement for 2025-11-01 through 2026-04-30. View: Product and service. Revenue and costs use their disclosed categories. - **Net revenue**: 3,633,000,000 US dollars - **Cost of revenue**: 1,697,000,000 US dollars - **Gross profit (calculated)**: 1,936,000,000 US dollars - **Operating expenses (calculated)**: 1,184,000,000 US dollars - **Income from operations**: 752,000,000 US dollars - **Other income (expense), net (calculated)**: 20,000,000 US dollars - **Income before taxes**: 772,000,000 US dollars - **Provision for income taxes**: 128,000,000 US dollars - **Net income**: 644,000,000 US dollars - **Product revenue**: 2,578,000,000 US dollars - **Services and Other revenue**: 1,055,000,000 US dollars - **Product cost of revenue**: 1,138,000,000 US dollars - **Services and Other cost of revenue**: 559,000,000 US dollars - **Research and development**: 243,000,000 US dollars - **Selling, general and administrative**: 941,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by End Markets - Page: https://plicit.ai/financials/a/fy2026-ytd-q2-income-statement/revenue-by-end-markets - Chart image: https://plicit.ai/charts/a-fy2026-ytd-q2-revenue-by-end-markets-sankey.png Income statement for 2025-11-01 through 2026-04-30. View: End Markets. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net revenue**: 3,633,000,000 US dollars - **Cost of revenue**: 1,697,000,000 US dollars - **Gross profit (calculated)**: 1,936,000,000 US dollars - **Operating expenses (calculated)**: 1,184,000,000 US dollars - **Income from operations**: 752,000,000 US dollars - **Other income (expense), net (calculated)**: 20,000,000 US dollars - **Income before taxes**: 772,000,000 US dollars - **Provision for income taxes**: 128,000,000 US dollars - **Net income**: 644,000,000 US dollars - **Pharmaceutical and Biotechnology Market**: 1,303,000,000 US dollars - **Diagnostics and Clinical Market**: 558,000,000 US dollars - **Academia and Government Market**: 262,000,000 US dollars - **Chemicals and Advanced Materials Market**: 834,000,000 US dollars - **Food Market**: 313,000,000 US dollars - **Environmental and Forensics Market**: 363,000,000 US dollars - **Research and development**: 243,000,000 US dollars - **Selling, general and administrative**: 941,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Geography - Page: https://plicit.ai/financials/a/fy2026-ytd-q2-income-statement/revenue-by-geography - Chart image: https://plicit.ai/charts/a-fy2026-ytd-q2-revenue-by-geography-sankey.png Income statement for 2025-11-01 through 2026-04-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net revenue**: 3,633,000,000 US dollars - **Cost of revenue**: 1,697,000,000 US dollars - **Gross profit (calculated)**: 1,936,000,000 US dollars - **Operating expenses (calculated)**: 1,184,000,000 US dollars - **Income from operations**: 752,000,000 US dollars - **Other income (expense), net (calculated)**: 20,000,000 US dollars - **Income before taxes**: 772,000,000 US dollars - **Provision for income taxes**: 128,000,000 US dollars - **Net income**: 644,000,000 US dollars - **Americas**: 1,442,000,000 US dollars - **Europe**: 1,036,000,000 US dollars - **Asia Pacific**: 1,155,000,000 US dollars - **Research and development**: 243,000,000 US dollars - **Selling, general and administrative**: 941,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.